Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health

Aimée Parker, Sonia Fonseca, Simon R Carding, Aimée Parker, Sonia Fonseca, Simon R Carding

Abstract

The human gastrointestinal (gut) microbiota comprises diverse and dynamic populations of bacteria, archaea, viruses, fungi, and protozoa, coexisting in a mutualistic relationship with the host. When intestinal homeostasis is perturbed, the function of the gastrointestinal tract and other organ systems, including the brain, can be compromised. The gut microbiota is proposed to contribute to blood-brain barrier disruption and the pathogenesis of neurodegenerative diseases. While progress is being made, a better understanding of interactions between gut microbes and host cells, and the impact these have on signaling from gut to brain is now required. In this review, we summarise current evidence of the impact gut microbes and their metabolites have on blood-brain barrier integrity and brain function, and the communication networks between the gastrointestinal tract and brain, which they may modulate. We also discuss the potential of microbiota modulation strategies as therapeutic tools for promoting and restoring brain health.

Keywords: Microbiota; blood-brain barrier; gut-brain axis; metabolites.

Figures

Figure 1.
Figure 1.
Schematic representation of the human blood-brain-barrier neurovascular-endothelial-unit in health (a) and disease (b) states. Increased permeability related to, for example trauma or infection, is associated with disruption of endothelial tight junctions leading to the ingress and translocation of blood-borne immune cells, and inflammatory mediators such as cytokines and microbes and their products that can activate microglia, resulting in local inflammation leading to loss of extracellular matrix and astrocyte, pericyte and neuronal cell dysfunction and death.
Figure 2.
Figure 2.
Pathways of communication along the gut-microbiota-brain axis. A complex interplay of epithelial, immune and neural cell signalling networks is involved in sensing and communicating changes in microbial metabolites in the gut and the brain involving both circulatory and neural routes.

References

    1. Duda-Chodak A, Tarko T, Satora P, Sroka P.. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. Eur J Nutr. 2015;54:325–341. doi:10.1007/s00394-015-0852-y.
    1. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533. doi:10.1371/journal.pbio.1002533.
    1. Laval L, Martin R, Natividad JN, Chain F, Miquel S, Desclee de Maredsous C, Capronnier S, Sokol H, Verdu EF, van Hylckama Vlieg JET, et al. Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice. Gut Microbes. 2015;6:1–9. doi:10.4161/19490976.2014.990784.
    1. Nash V, Ranadheera CS, Georgousopoulou EN, Mellor D, Panagiotakos DB, McKune A, Kellett J, Naumovski N. The effects of grape and red wine polyphenols on gut microbiota – a systematic review. Food Res Int (Ottawa, Ont). 2018;113:277–287. doi:10.1016/j.foodres.2018.07.019.
    1. Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20:145–155. doi:10.1038/nn.4476.
    1. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6:263ra158.
    1. Fröhlich EE, Farzi A, Mayerhofer R, Reichmann F, Jacan A, Wagner B, Zinser E, Bordag N, Magnes C, Fröhlich E, et al. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun. 2016;56:140–155. doi:10.1016/j.bbi.2016.02.020.
    1. Spielman LJ, Klegeris A. The role of insulin and incretins in neuroinflammation and neurodegeneration. Immunoendocrinology. 2014;1:e391. doi:10.14800/immunoendocrinology.391.
    1. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77–98. doi:10.1016/j.pneurobio.2005.06.004.
    1. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57–69. doi:10.1038/nrn2038.
    1. Campos-Bedolla P, Walter FR, Veszelka S, Deli MA. Role of the blood-brain barrier in the nutrition of the central nervous system. Arch Med Res. 2014;45:610–638. doi:10.1016/j.arcmed.2014.11.018.
    1. Harach T, Marungruang N, Dutilleul N, Cheatham V, Mc Coy K, Neher J, Jucker M, Fåk F, Bolmont T.. Reduction of Alzheimer’s disease beta-amyloid pathology in the absence of gut microbiota. arXiv:1509.02273v2. 2015.
    1. Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci Rep. 2016;6:30028. doi:10.1038/srep30028.
    1. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30:350–358. doi:10.1002/mds.26069.
    1. Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, et al. Gut microbiota regulate motor deficits and Neuroinflammation in a model of Parkinson’s disease. Cell. 2016;167:1469–80 e12. doi:10.1016/j.cell.2016.11.018.
    1. Stern L, Gautier R. Recherches Sur Le Liquide Céphalo-Rachidien: I.–les Rapports Entre Le Liquide Céphalo-Rachidien et la Circulation Sanguine. Arch Int Physiol. 1921;17:138–192. doi:10.3109/13813452109146211.
    1. Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969;40:648–677. doi:10.1083/jcb.40.3.648.
    1. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967;34:207–217. doi:10.1083/jcb.34.1.207.
    1. Ruck T, Bittner S, Meuth SG. Blood-brain barrier modeling: challenges and perspectives. Neural Regen Res. 2015;10:889–891. doi:10.4103/1673-5374.158342.
    1. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173–185. doi:10.1124/pr.57.2.4.
    1. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16:1–13. doi:10.1016/j.nbd.2003.12.016.
    1. Vorbrodt AW, Dobrogowska DH. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view. Brain Res Brain Res Rev. 2003;42:221–242.
    1. Rustenhoven J, Jansson D, Smyth LC, Dragunow M. Brain pericytes as mediators of neuroinflammation. Trends Pharmacol Sci. 2017;38:291–304. doi:10.1016/j.tips.2016.12.001.
    1. Moura RP, Almeida A, Sarmento B. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier. Prog Neurobiol. 2017;159:39–49. doi:10.1016/j.pneurobio.2017.09.001.
    1. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41–53. doi:10.1038/nrn1824.
    1. Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135:311–336. doi:10.1007/s00401-018-1815-1.
    1. Zhang J, Ke KF, Liu Z, Qiu YH, Peng YP. Th17 cell-mediated neuroinflammation is involved in neurodegeneration of abeta1-42-induced Alzheimer’s disease model rats. PLoS One. 2013;8:e75786. doi:10.1371/journal.pone.0075786.
    1. Sommer A, Maxreiter F, Krach F, Fadler T, Grosch J, Maroni M, Graef D, Eberhardt E, Riemenschneider MJ, Yeo GW, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson’s disease. Cell Stem Cell. 2018;23:123–31 e6. doi:10.1016/j.stem.2018.06.015.
    1. Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, Zlokovic BV. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun. 2013;4:2932. doi:10.1038/ncomms3932.
    1. Li H, Sun J, Du J, Wang F, Fang R, Yu C, Xiong J, Chen W, Lu Z, Liu J. Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis. Neurogastroenterol Motil. 2018;30:e13260. doi:10.1111/nmo.2018.30.issue-5.
    1. Li H, Sun J, Wang F, Ding G, Chen W, Fang R, Yao Y, Pang M, Lu Z-Q, Liu J. Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice. Brain Res. 2016;1642:70–78. doi:10.1016/j.brainres.2016.03.031.
    1. Quinn M, McMillin M, Galindo C, Frampton G, Pae HY, DeMorrow S. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. Dig Liver Dis. 2014;46:527–534. doi:10.1016/j.dld.2014.01.159.
    1. Hoyles L, Snelling T, Umlai UK, Nicholson JK, Carding SR, Glen RC, McArthur S. Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome. 2018;6:55. doi:10.1186/s40168-018-0432-5.
    1. Ganapathy V, Thangaraju M, Prasad PD, Martin PM, Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol. 2013;13:869–874. doi:10.1016/j.coph.2013.08.006.
    1. Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, Flint HJ, Louis P. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. Isme J. 2014;8:1323–1335. doi:10.1038/ismej.2014.14.
    1. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80:S147–71.
    1. Macfabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. 2012;23:19260. doi:10.3402/mehd.v23i0.19260.
    1. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther. 2007;321:892–901. doi:10.1124/jpet.107.120188.
    1. Matt SM, Allen JM, Lawson MA, Mailing LJ, Woods JA, Johnson RW. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice. Front Immunol. 2018;9:1832. doi:10.3389/fimmu.2018.01832.
    1. Fischer A, Radulovic M, Schrick C, Sananbenesi F, Godovac-Zimmermann J, Radulovic J. Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior. Neurobiol Learn Mem. 2007;87:149–158. doi:10.1016/j.nlm.2006.08.003.
    1. MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp K-P. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007;176:149–169. doi:10.1016/j.bbr.2006.07.025.
    1. Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965–977. doi:10.1038/nn.4030.
    1. Zilberter Y, Zilberter M. The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction. J Neurosci Res. 2017;95:2217–2235. doi:10.1002/jnr.24064.
    1. Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ. 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain. Front Aging Neurosci. 2017;9:195. doi:10.3389/fnagi.2017.00077.
    1. Readhead B, Haure-Mirande JV, Funk CC, Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann ND, Price ND, et al. Multiscale Analysis of independent Alzheimer’s Cohorts finds disruption of molecular, genetic, and clinical networks by human Herpesvirus. Neuron. 2018;99:64–82 e7. doi:10.1016/j.neuron.2018.05.023.
    1. Pisa D, Alonso R, Fernandez-Fernandez AM, Rabano A, Carrasco L. Polymicrobial infections in brain tissue from Alzheimer’s disease patients. Sci Rep. 2017;7:5559. doi:10.1038/s41598-017-05903-y.
    1. Pisa D, Alonso R, Rabano A, Rodal I, Carrasco L. Different brain regions are infected with fungi in Alzheimer’s disease. Sci Rep. 2015;5:15015. doi:10.1038/srep15015.
    1. Pisa D, Alonso R, Juarranz A, Rabano A, Carrasco L. Direct visualization of fungal infection in brains from patients with Alzheimer’s disease. J Alzheimers Dis. 2015;43:613–624. doi:10.3233/JAD-141386.
    1. Bensasson D, Dicks J, Ludwig JM, Bond CJ, Elliston A, Roberts IN, James SA. Diverse Lineages of Candida albicans live on old Oaks. Genetics. 2019;211:277–288. doi:10.1534/genetics.118.301482.
    1. Lachance M-A, Boekhout T, Scorzetti G, Fell JW, Kurtzman CP. Candida Berkhout (1923). In: Kurtzman CP, Fell JW, Boekhout T, editors. The yeasts. Elsevier; 2011. p. 987–1278. doi:10.1016/B978-0-444-52149-1.00090-2.
    1. Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17:49–60. doi:10.1016/j.cmet.2012.12.011.
    1. Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio. 2015;6:e02481. doi:10.1128/mBio.02481-14.
    1. Del Rio D, Zimetti F, Caffarra P, Tassotti M, Bernini F, Brighenti F, Zini A, Zanotti I. The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid. Nutrients. 2017;9:1053.
    1. Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng T-YD, et al. Plasma choline metabolites and colorectal cancer risk in the women’s health initiative observational study. Cancer Res. 2014;74:7442–7452. doi:10.1158/0008-5472.CAN-14-1835.
    1. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576–585. doi:10.1038/nm.3145.
    1. Brugere JF, Borrel G, Gaci N, Tottey W, O’Toole PW, Malpuech-Brugere C. Archaebiotics: proposed therapeutic use of Archaea to prevent trimethylaminuria and cardiovascular disease. Gut Microbes. 2014;5:5–10. doi:10.4161/gmic.26749.
    1. Gaci N, Borrel G, Tottey W, O’Toole PW, Brugere JF. Archaea and the human gut: new beginning of an old story. World J Gastroenterol. 2014;20:16062–16078. doi:10.3748/wjg.v20.i43.16062.
    1. Nkamga VD, Lotte R, Chirio D, Lonjon M, Roger PM, Drancourt M, Ruimy R. Methanobrevibacter oralis detected along with Aggregatibacter actinomycetemcomitans in a series of community-acquired brain abscesses. Clin Microbiol Infect. 2018;24:207–208. doi:10.1016/j.cmi.2017.08.021.
    1. Dumas ME, Rothwell AR, Hoyles L, Aranias T, Chilloux J, Calderari S, Noll EM, Péan N, Boulangé CL, Blancher C, et al. Microbial-Host Co-metabolites are prodromal markers predicting Phenotypic Heterogeneity in behavior, obesity, and impaired glucose tolerance. Cell Rep. 2017;20:136–148. doi:10.1016/j.celrep.2017.06.039.
    1. Lupachyk S, Watcho P, Stavniichuk R, Shevalye H, Obrosova IG. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes. 2013;62:944–952. doi:10.2337/db12-0716.
    1. Matsumoto T, Nagase Y, Hirose J, Tokuyama N, Yasui T, Kadono Y, Ueki K, Kadowaki T, Nakamura K, Tanaka S. Regulation of bone resorption and sealing zone formation in osteoclasts occurs through protein kinase B-mediated microtubule stabilization. J Bone Miner Res. 2013;28:1191–1202. doi:10.1002/jbmr.1844.
    1. Tseng HC, Graves DJ. Natural methylamine osmolytes, trimethylamine N-oxide and betaine, increase tau-induced polymerization of microtubules. Biochem Biophys Res Commun. 1998;250:726–730. doi:10.1006/bbrc.1998.9382.
    1. Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell. 1997;89:297–308.
    1. Xu R, Wang Q. Towards understanding brain-gut-microbiome connections in Alzheimer’s disease. BMC Syst Biol. 2016;10(Suppl 3):63. doi:10.1186/s12918-016-0304-1.
    1. Yang DS, Yip CM, Huang TH, Chakrabartty A, Fraser PE. Manipulating the amyloid-beta aggregation pathway with chemical chaperones. J Biol Chem. 1999;274:32970–32974. doi:10.1074/jbc.274.46.32970.
    1. Bose S, Cho J. Targeting chaperones, heat shock factor-1, and unfolded protein response: promising therapeutic approaches for neurodegenerative disorders. Ageing Res Rev. 2017;35:155–175. doi:10.1016/j.arr.2016.09.004.
    1. Wang S, Cui W, Zeng M, Ren Y, Han S, Li J. The increased release of amino acid neurotransmitters of the primary somatosensory cortical area in rats contributes to remifentanil-induced hyperalgesia and its inhibition by lidocaine. J Pain Res. 2018;11:1521–1529. doi:10.2147/JPR.S168008.
    1. Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113:411–417. doi:10.1111/j.1365-2672.2012.05344.x.
    1. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23:716–724. doi:10.1016/j.chom.2018.05.003.
    1. Williams BB, Van Benschoten AH, Cimermancic P, Donia MS, Zimmermann M, Taketani M, Ishihara A, Kashyap PC, Fraser JS, Fischbach MA. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 2014;16:495–503. doi:10.1016/j.chom.2014.09.001.
    1. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–276. doi:10.1016/j.cell.2015.02.047.
    1. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013;18:666–673. doi:10.1038/mp.2012.77.
    1. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43:164–174. doi:10.1016/j.jpsychires.2008.03.009.
    1. Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, Chao -C-C, Patel B, Yan R, Blain M, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22:586–597. doi:10.1038/nm.4106.
    1. Alkhalaf LM, Ryan KS. Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chem Biol. 2015;22:317–328. doi:10.1016/j.chembiol.2015.02.005.
    1. Kaszaki J, Erces D, Varga G, Szabo A, Vecsei L, Boros M. Kynurenines and intestinal neurotransmission: the role of N-methyl-D-aspartate receptors. J Neural Transm (Vienna). 2012;119:211–223. doi:10.1007/s00702-011-0658-x.
    1. Stone TW, Darlington LG. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol. 2013;169:1211–1227. doi:10.1111/bph.12230.
    1. Saito K, Markey SP, Heyes MP. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience. 1992;51:25–39.
    1. Fujigaki H, Yamamoto Y, Saito K. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences. Neuropharmacology. 2017;112:264–274. doi:10.1016/j.neuropharm.2016.01.011.
    1. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24:160–168. doi:10.1016/j.copbio.2012.08.005.
    1. Said HM, Mohammed ZM. Intestinal absorption of water-soluble vitamins: an update. Curr Opin Gastroenterol. 2006;22:140–146. doi:10.1097/01.mog.0000203870.22706.52.
    1. Merli GJ, Fink J. Vitamin K and thrombosis. Vitam Horm. 2008;78:265–279. doi:10.1016/S0083-6729(07)00013-1.
    1. McMillan D, Perreault T, Watanabe M, Chance G, Askin DF, Hall J. Neonatal personnel in Canada. Paediatr Child Health. 1997;2:193–197. doi:10.1093/pch/2.3.193.
    1. Allison AC. The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease. Med Hypotheses. 2001;57:151–155. doi:10.1054/mehy.2001.1307.
    1. Da Silva FL, Coelho Cerqueira E, de Freitas MS, Goncalves DL, Costa LT, Follmer C. Vitamins K interact with N-terminus alpha-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and alpha-synuclein. Neurochem Int. 2013;62:103–112. doi:10.1016/j.neuint.2012.10.001.
    1. Soutif-Veillon A, Ferland G, Rolland Y, Presse N, Boucher K, Feart C, Annweiler C. Increased dietary vitamin K intake is associated with less severe subjective memory complaint among older adults. Maturitas. 2016;93:131–136. doi:10.1016/j.maturitas.2016.02.004.
    1. Hu J, Nie Y, Chen J, Zhang Y, Wang Z, Fan Q, Yan X. Gradual changes of gut microbiota in weaned miniature Piglets. Front Microbiol. 2016;7:1727. doi:10.3389/fmicb.2016.01727.
    1. Langohr HD, Petruch F, Schroth G. Vitamin B 1, B 2 and B 6 deficiency in neurological disorders. J Neurol. 1981;225:95–108.
    1. Finglas PM, Wright AJ, Wolfe CA, Hart DJ, Wright DM, Dainty JR. Is there more to folates than neural-tube defects? Proc Nutr Soc. 2003;62:591–598. doi:10.1079/PNS2003271.
    1. Owen RT. Folate augmentation of antidepressant response. Drugs Today (Barc). 2013;49:791–798. doi:10.1358/dot.2013.49.12.2086138.
    1. Pan LA, Martin P, Zimmer T, Segreti AM, Kassiff S, McKain BW, Baca CA, Rengasamy M, Hyland K, Walano N, et al. Neurometabolic disorders: potentially Treatable abnormalities in patients with treatment-refractory depression and suicidal behavior. Am J Psychiatry. 2017;174:42–50. doi:10.1176/appi.ajp.2016.15111500.
    1. Agnew-Blais JC, Wassertheil-Smoller S, Kang JH, Hogan PE, Coker LH, Snetselaar LG, Smoller JW. Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the women’s health initiative memory study. J Acad Nutr Diet. 2015;115:231–241. doi:10.1016/j.jand.2014.07.006.
    1. Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A. 2013;110:9523–9528. doi:10.1073/pnas.1301816110.
    1. Andermann ML, Lowell BB. Toward a wiring diagram understanding of appetite control. Neuron. 2017;95:757–778. doi:10.1016/j.neuron.2017.06.014.
    1. Brookes SJ, Spencer NJ, Costa M, Zagorodnyuk VP. Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol. 2013;10:286–296. doi:10.1038/nrgastro.2013.29.
    1. Gribble FM, Reimann F. Enteroendocrine cells: chemosensors in the intestinal epithelium. Annu Rev Physiol. 2016;78:277–299. doi:10.1146/annurev-physiol-021115-105439.
    1. Roth GS. Mechanisms of altered hormone-neurotransmitter action during aging: from receptors to calcium mobilization. Annu Rev Gerontol Geriatr. 1990;10:132–146.
    1. Kaelberer MM, Bohorquez DV. The now and then of gut-brain signaling. Brain Res. 2018;1693:192–196. doi:10.1016/j.brainres.2018.03.027.
    1. Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, Shen X, DV Bohórquez. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018;361:eaat5236. doi:10.1126/science.aat5236.
    1. Lauritzen KH, Morland C, Puchades M, Holm-Hansen S, Hagelin EM, Lauritzen F, Attramadal H, Storm-Mathisen J, Gjedde A, Bergersen LH. Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism. Cereb Cortex. 2014;24:2784–2795. doi:10.1093/cercor/bht136.
    1. McAllister MS, Krizanac-Bengez L, Macchia F, Naftalin RJ, Pedley KC, Mayberg MR, Marroni M, Leaman S, Stanness KA, Janigro D. Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. Brain Res. 2001;904:20–30. doi:10.1016/s0006-8993(01)02418-0.
    1. Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci. 2002;18:7–14. doi:10.1385/JMN:18:1-2:07.
    1. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci. 2003;23:2939–2946.
    1. Kieffer TJ, McIntosh CH, Pederson RA. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology. 1995;136:3585–3596. doi:10.1210/endo.136.8.7628397.
    1. Neunlist M, Schemann M. Nutrient-induced changes in the phenotype and function of the enteric nervous system. J Physiol. 2014;592:2959–2965. doi:10.1113/jphysiol.2014.272948.
    1. Abot A, Cani PD, Knauf C. Impact of intestinal peptides on the enteric nervous system: novel approaches to control glucose metabolism and food intake. Front Endocrinol (Lausanne). 2018;9:328. doi:10.3389/fendo.2018.00420.
    1. Su Z, Alhadeff AL, Betley JN. Nutritive, post-ingestive signals are the primary regulators of AgRP neuron activity. Cell Rep. 2017;21:2724–2736. doi:10.1016/j.celrep.2017.11.036.
    1. Dockray GJ. Enteroendocrine cell signalling via the vagus nerve. Curr Opin Pharmacol. 2013;13:954–958. doi:10.1016/j.coph.2013.09.007.
    1. Nohr MK, Egerod KL, Christiansen SH, Gille A, Offermanns S, Schwartz TW, Møller M. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience. 2015;290:126–137. doi:10.1016/j.neuroscience.2015.01.040.
    1. Poole DP, Godfrey C, Cattaruzza F, Cottrell GS, Kirkland JG, Pelayo JC, Bunnett NW, CU Corvera, et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil. 2010;22(814–25):e227–8. doi:10.1111/j.1365-2982.2010.01487.x.
    1. Soret R, Chevalier J, De Coppet P, Poupeau G, Derkinderen P, Segain JP, Neunlist M. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology. 2010;138:1772–1782. doi:10.1053/j.gastro.2010.01.053.
    1. Vincent KM, Sharp JW, Raybould HE. Intestinal glucose-induced calcium-calmodulin kinase signaling in the gut-brain axis in awake rats. Neurogastroenterol Motil. 2011;23:e282–93. doi:10.1111/j.1365-2982.2011.01673.x.
    1. Bohorquez DV, Shahid RA, Erdmann A, Kreger AM, Wang Y, Calakos N, Wang F, Liddle RA. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest. 2015;125:782–786. doi:10.1172/JCI78361.
    1. Schretter CE, Vielmetter J, Bartos I, Marka Z, Marka S, Argade S, Mazmanian SK. A gut microbial factor modulates locomotor behaviour in Drosophila. Nature. 2018;563:402–406. doi:10.1038/s41586-018-0634-9.
    1. Zhao HW, Yue YH, Han H, Chen XL, Lu YG, Zheng JM, Hou H-T, Lang X-M, He -L-L, Hu Q-L, et al. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. World J Gastroenterol. 2017;23:999–1009. doi:10.3748/wjg.v23.i6.999.
    1. Mark KS, Miller DW. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sci. 1999;64:1941–1953. doi:10.1016/s0024-3205(99)00139-3.
    1. Thomsen MS, Birkelund S, Burkhart A, Stensballe A, Moos T. Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier. J Neurochem. 2017;140:741–754. doi:10.1111/jnc.13747.
    1. Perry VH. Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain. Brain Behav Immun. 2007;21:45–46. doi:10.1016/j.bbi.2006.08.004.
    1. Wu SC, Cao ZS, Chang KM, Juang JL. Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in Drosophila. Nat Commun. 2017;8:24. doi:10.1038/s41467-017-00040-6.
    1. Williams SK, Fairless R, Maier O, Liermann PC, Pichi K, Fischer R, Eisel ULM, Kontermann R, Herrmann A, Weksler B, et al. Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis. Sci Rep. 2018;8:13628. doi:10.1038/s41598-018-31957-7.
    1. Becker L, Nguyen L, Gill J, Kulkarni S, Pasricha PJ, Habtezion A. Age-dependent shift in macrophage polarisation causes inflammation-mediated degeneration of enteric nervous system. Gut. 2018;67:827–836. doi:10.1136/gutjnl-2016-312940.
    1. Rosenbaum C, Schick MA, Wollborn J, Heider A, Scholz CJ, Cecil A, Niesler B, Hirrlinger J, Walles H, Metzger M, et al. Activation of myenteric Glia during acute inflammation in vitro and in vivo. PLoS One. 2016;11:e0151335. doi:10.1371/journal.pone.0151335.
    1. Alkahtani SH. The steroidal Na+/K+ ATPase inhibitor 3-[(R)-3-pyrrolidinyl]oxime derivative (3-R-POD) induces potent pro-apoptotic responses in colonic tumor cells. Anticancer Res. 2014;34:2967–2971.
    1. Kabouridis PS, Lasrado R, McCallum S, Chng SH, Snippert HJ, Clevers H, Pettersson S, Pachnis V. The gut microbiota keeps enteric glial cells on the move; prospective roles of the gut epithelium and immune system. Gut Microbes. 2015;6:398–403. doi:10.1080/19490976.2015.1109767.
    1. Ibiza S, Garcia-Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, Misic AM, Bartow-McKenney C, Larson DM, Pavan WJ, et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature. 2016;535:440–443. doi:10.1038/nature18644.
    1. Jackerott M, Larsson LI. Immunocytochemical localization of the NPY/PYY Y1 receptor in enteric neurons, endothelial cells, and endocrine-like cells of the rat intestinal tract. J Histochem Cytochem. 1997;45:1643–1650. doi:10.1177/002215549704501207.
    1. Terry N, Margolis KG. Serotonergic mechanisms regulating the GI tract: experimental evidence and therapeutic relevance. Handb Exp Pharmacol. 2017;239:319–342. doi:10.1007/164_2016_103.
    1. Takaki M, Branchek T, Tamir H, Gershon MD. Specific antagonism of enteric neural serotonin receptors by dipeptides of 5-hydroxytryptophan: evidence that serotonin is a mediator of slow synaptic excitation in the myenteric plexus. J Neurosci. 1985;5:1769–1780.
    1. Williams DA, Zaidi SA, Zhang Y. 5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor. Bioorg Med Chem Lett. 2014;24:1489–1492. doi:10.1016/j.bmcl.2014.02.029.
    1. De Vadder F, Grasset E, Manneras Holm L, Karsenty G, Macpherson AJ, Olofsson LE, Bäckhed F. Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks. Proc Natl Acad Sci U S A. 2018;115:6458–6463. doi:10.1073/pnas.1720017115.
    1. Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q. Neurotransmitter receptors and cognitive dysfunction in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol. 2012;97:1–13. doi:10.1016/j.pneurobio.2012.02.002.
    1. Barajon I, Serrao G, Arnaboldi F, Opizzi E, Ripamonti G, Balsari A, Rumio C. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem. 2009;57:1013–1023. doi:10.1369/jhc.2009.953539.
    1. Brun P, Giron MC, Qesari M, Porzionato A, Caputi V, Zoppellaro C, Banzato S, Grillo AR, Spagnol L, De Caro R, et al. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology. 2013;145:1323–1333. doi:10.1053/j.gastro.2013.08.047.
    1. Spielman LJ, Gibson DL, Klegeris A. Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases. Neurochem Int. 2018;120:149–163. doi:10.1016/j.neuint.2018.08.005.
    1. Hyland NP, Cryan JF. A Gut Feeling about GABA: focus on GABA(B) Receptors. Front Pharmacol. 2010;1:124. doi:10.3389/fphar.2010.00124.
    1. Ji XB, Hollocher TC. Reduction of nitrite to nitric oxide by enteric bacteria. Biochem Biophys Res Commun. 1988;157:106–108. doi:10.1016/s0006-291x(88)80018-4.
    1. Stanaszek PM, Snell JF, O’Neill JJ. Isolation, extraction, and measurement of acetylcholine from Lactobacillus plantarum. Appl Environ Microbiol. 1977;34:237–239.
    1. Tsavkelova EA, Botvinko IV, Kudrin VS, Oleskin AV. Detection of neurotransmitter amines in microorganisms with the use of high-performance liquid chromatography. Dokl Biochem. 2000;372:115–117.
    1. Özoğul F. Production of biogenic amines by Morganella morganii, Klebsiella pneumoniae and Hafnia alvei using a rapid HPLC method. Eur Food Res Technol. 2004;219:465–469. doi:10.1007/s00217-004-0988-0.
    1. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74:720–726. doi:10.1016/j.biopsych.2013.05.001.
    1. Bambury A, Sandhu K, Cryan JF, Dinan TG. Finding the needle in the haystack: systematic identification of psychobiotics. Br J Pharmacol. 2018;175:4430–4438. doi:10.1111/bph.14127.
    1. Skelly DT, Hennessy E, Dansereau MA, Cunningham C. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1beta, [corrected] TNF-alpha and IL-6 challenges in C57BL/6 mice. PLoS One. 2013;8:e69123. doi:10.1371/journal.pone.0069123.
    1. Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014;15:367–378. doi:10.1038/nrn3745.
    1. Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, Sita G, Racchumi G, Ling L, Pamer EG, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med. 2016;22:516–523. doi:10.1038/nm.4068.
    1. Banks WA. Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology. 2012;153:4111–4119. doi:10.1210/en.2012-1435.
    1. Louveau A, Herz J, Alme MN, Salvador AF, Dong MQ, Viar KE, Herod SG, Knopp J, Setliff JC, Lupi AL, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380–1391. doi:10.1038/s41593-018-0227-9.
    1. Herisson F, Frodermann V, Courties G, Rohde D, Sun Y, Vandoorne K, Wojtkiewicz GR, Masson GS, Vinegoni C, Kim J, et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci. 2018;21:1209–1217. doi:10.1038/s41593-018-0213-2.
    1. Nakamura YK, Janowitz C, Metea C, Asquith M, Karstens L, Rosenbaum JT, Lin P. Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep. 2017;7:11745. doi:10.1038/s41598-017-12163-3.
    1. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318:121–134. doi:10.1007/s00441-004-0956-9.
    1. Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van Den Haute C, Melki R, Baekelandt V. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015;522:340–344. doi:10.1038/nature14547.
    1. Breen DP, Halliday GM, Lang AE. Gut-brain axis and the spread of alpha-synuclein pathology: vagal highway or dead end? Mov Disord. 2019;34:307–316. doi:10.1002/mds.27556.
    1. Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, et al. Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One. 2010;5:e8762. doi:10.1371/journal.pone.0008762.
    1. Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O’Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012;2:898. doi:10.1038/srep00386.
    1. Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang Z-Y, Roybon L, Melki R, Li J-Y. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805–820. doi:10.1007/s00401-014-1343-6.
    1. Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13:21. doi:10.1186/s13024-018-0257-5.
    1. Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA. alpha-Synuclein in gut endocrine cells and its implications for Parkinson’s disease. JCI Insight. 2017;2:e92295. doi:10.1172/jci.insight.92295.
    1. Rey NL, Petit GH, Bousset L, Melki R, Brundin P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 2013;126:555–573. doi:10.1007/s00401-013-1160-3.
    1. Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sørensen HT. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78:522–529. doi:10.1002/ana.24448.
    1. Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, Svenningsson P, Chen H, Wirdefeldt K. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology. 2017;88:1996–2002. doi:10.1212/WNL.0000000000003961.
    1. Lin SY, Lin CL, Wang IK, Lin CC, Lin CH, Hsu WH, Kao C-H. Dementia and vagotomy in Taiwan: a population-based cohort study. BMJ Open. 2018;8:e019582. doi:10.1136/bmjopen-2017-019582.
    1. Guinane CM, Tadrous A, Fouhy F, Ryan CA, Dempsey EM, Murphy B, Andrews E, Cotter PD, Stanton C, Ross RP. Microbial composition of human appendices from patients following appendectomy. MBio. 2013;4:e00366-12. doi:10.1128/mBio.00366-12.
    1. Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord. 2014;29:991–998. doi:10.1002/mds.25779.
    1. Mendes A, Goncalves A, Vila-Cha N, Moreira I, Fernandes J, Damasio J, Teixeira-Pinto A, Taipa R, Lima AB, Cavaco S. Appendectomy may delay Parkinson’s disease Onset. Mov Disord. 2015;30:1404–1407. doi:10.1002/mds.26311.
    1. Yilmaz R, Bayram E, Ulukan C, Altinok MK, Akbostanci MC. Appendectomy history is not related to Parkinson’s Disease. J Parkinsons Dis. 2017;7:347–352. doi:10.3233/JPD-171071.
    1. Marras C, Lang AE, Austin PC, Lau C, Urbach DR. Appendectomy in mid and later life and risk of Parkinson’s disease: a population-based study. Mov Disord. 2016;31:1243–1247. doi:10.1002/mds.26670.
    1. Svensson E, Horvath-Puho E, Stokholm MG, Sorensen HT, Henderson VW, Borghammer P. Appendectomy and risk of Parkinson’s disease: a nationwide cohort study with more than 10 years of follow-up. Mov Disord. 2016;31:1918–1922. doi:10.1002/mds.26761.
    1. Chen SG, Stribinskis V, Rane MJ, Demuth DR, Gozal E, Roberts AM, Jagadapillai R, Liu R, Choe K, Shivakumar B, et al. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and Caenorhabditis elegans. Sci Rep. 2016;6:34477. doi:10.1038/srep34477.
    1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401–1412. doi:10.1093/jn/125.6.1401.
    1. Roberfroid M. Probiotics and prebiotics: why should the medical community pay attention? Drug Discov Today. 2003;8:1107–1108.
    1. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 2010;29:701–725. doi:10.1016/j.clnu.2010.05.004.
    1. Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12:303–310. doi:10.1038/nrgastro.2015.47.
    1. Savignac HM, Corona G, Mills H, Chen L, Spencer JP, Tzortzis G, Burnet PWJ. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int. 2013;63:756–764. doi:10.1016/j.neuint.2013.10.006.
    1. Kao A-C-C, Chan KW, Anthony DC, Lennox BR, Burnet PW. Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats, are acetate independent. Neuropharmacology. 2019;150:184–191. doi:10.1016/j.neuropharm.2019.02.014.
    1. Mika A, Gaffney M, Roller R, Hills A, Bouchet CA, Hulen KA, Thompson RS, Chichlowski M, Berg BM, Fleshner M. Feeding the developing brain: juvenile rats fed diet rich in prebiotics and bioactive milk fractions exhibit reduced anxiety-related behavior and modified gene expression in emotion circuits. Neurosci Lett. 2018;677:103–109. doi:10.1016/j.neulet.2018.01.052.
    1. de Cossío LF, Fourrier C, Sauvant J, Everard A, Capuron L, Cani PD, Layé S, Castanon N. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome. Brain Behav Immun. 2017;64:33–49. doi:10.1016/j.bbi.2016.12.022.
    1. Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G, Stanton C, Dinan TG, Cryan JF. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry. 2017;82:472–487. doi:10.1016/j.biopsych.2016.12.031.
    1. Crumeyrolle-Arias M, Jaglin M, Bruneau A, Vancassel S, Cardona A, Dauge V, Naudon L, Rabot S. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology. 2014;42:207–217. doi:10.1016/j.psyneuen.2014.01.014.
    1. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558:263–275. doi:10.1113/jphysiol.2004.063388.
    1. Kao AC, Spitzer S, Anthony DC, Lennox B, Burnet PWJ. Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota. Transl Psychiatry. 2018;8:66. doi:10.1038/s41398-018-0116-8.
    1. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl). 2015;232:1793–1801. doi:10.1007/s00213-014-3810-0.
    1. van Den Berg JP, Westerbeek EA, Broring-Starre T, Garssen J, van Elburg RM. Neurodevelopment of preterm infants at 24 months after neonatal supplementation of a prebiotic mix: a randomized trial. J Pediatr Gastroenterol Nutr. 2016;63:270–276.
    1. Romo-Araiza A, Gutierrez-Salmean G, Galvan EJ, Hernandez-Frausto M, Herrera-Lopez G, Romo-Parra H, García-Contreras V, Fernández-Presas AM, Jasso-Chávez R, Borlongan CV, et al. Probiotics and prebiotics as a therapeutic strategy to improve memory in a model of middle-aged rats. Front Aging Neurosci. 2018;10:416. doi:10.3389/fnagi.2018.00416.
    1. Rajkumar H, Kumar M, Das N, Kumar SN, Challa HR, Nagpal R. Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on Serum Lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J Cardiovasc Pharmacol Ther. 2015;20:289–298. doi:10.1177/1074248414555004.
    1. De Paula JA, Carmuega E, Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam. 2008;38:16–25.
    1. FAO/WHO . Expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Córdoba (Argentina) October 2001:1–4.
    1. Kunes J, Prazienkova V, Popelova A, Mikulaskova B, Zemenova J, Maletinska L. Prolactin-releasing peptide: a new tool for obesity treatment. J Endocrinol. 2016;230:R51–8. doi:10.1530/JOE-16-0046.
    1. Cani PD, de Vos WM. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol. 2017;8:1765. doi:10.3389/fmicb.2017.01765.
    1. Breyner NM, Michon C, de Sousa CS, Vilas Boas PB, Chain F, Azevedo VA, Langella P, Chatel JM. Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-kappaB pathway. Front Microbiol. 2017;8:114. doi:10.3389/fmicb.2017.00114.
    1. Hamady ZZ, Scott N, Farrar MD, Lodge JP, Holland KT, Whitehead T, Carding SR. Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut. 2010;59:461–469. doi:10.1136/gut.2008.176131.
    1. Saarela MH. Safety aspects of next generation probiotics. Curr Opin Food Sci. 2019;30:8–13. doi:10.1016/j.cofs.2018.09.001.
    1. Aguilar-Toala JE, Astiazaran-Garcia H, Estrada-Montoya MC, Garcia HS, Vallejo-Cordoba B, Gonzalez-Cordova AF, Hernández-Mendoza A. Modulatory effect of the intracellular content of Lactobacillus casei CRL 431 against the aflatoxin B1-Induced oxidative stress in rats. Probiotics Antimicrob Proteins. 2019;11:470–477. doi:10.1007/s12602-018-9433-8.
    1. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 2011;6:261–274. doi:10.1007/s12263-011-0218-x.
    1. Tsilingiri K, Rescigno M. Postbiotics: what else? Benef Microbes. 2013;4:101–107. doi:10.3920/BM2012.0046.
    1. Phillips JGP. The treatment of melancholia by the lactic acid bacillus. J Mental Sci. 1910;56:422–430. doi:10.1192/bjp.56.234.422.
    1. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson J-F, Rougeot C, Pichelin M, Cazaubiel M, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105:755–764. doi:10.1017/S0007114510004319.
    1. Kato-Kataoka A, Nishida K, Takada M, Suda K, Kawai M, Shimizu K, Kushiro A, Hoshi R, Watanabe O, Igarashi T, et al. Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress. Benef Microbes. 2016;7:153–156. doi:10.3920/BM2015.0100.
    1. Slykerman RF, Hood F, Wickens K, Thompson JMD, Barthow C, Murphy R, Kang J, Rowden J, Stone P, Crane J, et al. Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: a Randomised Double-blind Placebo-controlled Trial. EBioMedicine. 2017;24:159–165. doi:10.1016/j.ebiom.2017.09.013.
    1. Lu Z, Zhang W, Zhang N, Jiang J, Luo Q, Qiu Y. The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative study. Neurol Res. 2008;30:915–919. doi:10.1179/174313208X327964.
    1. Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PWJ. Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals. Trends Neurosci. 2016;39:763–781. doi:10.1016/j.tins.2016.09.002.
    1. Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L, Barichella M. Use of probiotics for the treatment of constipation in Parkinson’s disease patients. Minerva Gastroenterol Dietol. 2011;57:117–121.
    1. Barichella M, Pacchetti C, Bolliri C, Cassani E, Iorio L, Pusani C, Pinelli G, Privitera G, Cesari I, Faierman SA, et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT. Neurology. 2016;87:1274–1280. doi:10.1212/WNL.0000000000003127.
    1. Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, Oryan S, Mafi A, Asemi Z. Clinical and metabolic response to probiotic administration in people with Parkinson’s disease: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019;38:1031–1035. doi:10.1016/j.clnu.2018.05.018.
    1. Nimgampalle M, Kuna Y. Anti-Alzheimer properties of probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer’s Disease induced Albino rats. J Clin Diagn Res. 2017;11:KC01–KC5. doi:10.7860/JCDR/2017/26106.10428.
    1. Athari Nik Azm S, Djazayeri A, Safa M, Azami K, Ahmadvand B, Sabbaghziarani F, Sharifzadeh M, Vafa M. Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in beta-amyloid (1-42) injected rats. Appl Physiol Nutr Metab. 2018;43:718–726. doi:10.1139/apnm-2017-0648.
    1. Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C, Fiorini D, Boarelli MC, Rossi G, Eleuteri AM. Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep. 2017;7:2426. doi:10.1038/s41598-017-02587-2.
    1. Leblhuber F, Steiner K, Schuetz B, Fuchs D, Gostner JM. Probiotic Supplementation in patients with Alzheimer’s Dementia - an explorative intervention study. Curr Alzheimer Res. 2018;15:1106–1113. doi:10.2174/1389200219666180813144834.
    1. Kobayashi Y, Kinoshita T, Matsumoto A, Yoshino K, Saito I, Xiao JZ. Bifidobacterium breve A1 supplementation improved cognitive decline in older adults with mild cognitive impairment: an open-label, single-arm study. J Prev Alzheimers Dis. 2019;6:70–75. doi:10.14283/jpad.2018.32.
    1. Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, Hamidi GA, Salami M. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci. 2016;8:256. doi:10.3389/fnagi.2016.00256.
    1. Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, Tajabadi-Ebrahimi M, Asemi Z. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial. Clin Nutr. 2018. doi:10.1016/j.clnu.2018.11.034.
    1. Staley C, Khoruts A, Sadowsky MJ. Contemporary applications of fecal microbiota transplantation to treat intestinal diseases in humans. Arch Med Res. 2017;48:766–773. doi:10.1016/j.arcmed.2017.11.006.
    1. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012;107:1755. author reply p −6. doi:10.1038/ajg.2012.251.
    1. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe. 2009;15:285–289. doi:10.1016/j.anaerobe.2009.09.007.
    1. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102–9 e6. doi:10.1053/j.gastro.2015.04.001.
    1. Schmulson M, Bashashati M. Fecal microbiota transfer for bowel disorders: efficacy or hype? Curr Opin Pharmacol. 2018;43:72–80. doi:10.1016/j.coph.2018.08.012.
    1. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(599–609):e1–3. doi:10.1053/j.gastro.2011.04.052.
    1. Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016;21:786–796. doi:10.1038/mp.2016.44.
    1. Kelly JR, Borre Y, OB C, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. 2016;82:109–118. doi:10.1016/j.jpsychires.2016.07.019.
    1. McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav. 2008;7:152–163. doi:10.1111/j.1601-183X.2007.00330.x.
    1. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13:465–477. doi:10.1038/nrn3257.
    1. Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, Cui C, Shen Y-Q. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: gut microbiota, glial reaction and TLR4/TNF-alpha signaling pathway. Brain Behav Immun. 2018;70:48–60. doi:10.1016/j.bbi.2018.02.005.
    1. Ananthaswamy A Faecal transplant eases symptoms of Parkinson’s disease. Elsevier, 2011.
    1. Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review. Gut Microbes. 2017;8:225–237. doi:10.1080/19490976.2017.1286006.
    1. Smith P, Willemsen D, Popkes M, Metge F, Gandiwa E, Reichard M, Valenzano DR. Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife. 2017;6:e27014. doi:10.7554/eLife.27014.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe